News Story: Full Text
Sponsored By
Orbus Therapeutics Inc Clinical Trial for Recurrent Anaplastic Astrocytomas
Please Click On The Above Banner For More Details
Braintumor Website


Promising brain cancer trial given breakthrough status by FDA


Al Musella's Comments: (This is his personal views and are not necessarily the views of the Musella Foundation!)

 This may be one of the most important news articles of the year.  This will give the trial the green light to start all over the country - and if successful, may  quickly lead to FDA approval. There will be a story about this treatment on "60 Minutes" on Sunday.  

Disclaimer - I am on the patient advisory board of The Brain Tumor Center at Duke, but have no financial interest in it.


Posted on: 05/12/2016

 

 

Promising brain cancer trial given breakthrough status by FDA

 

 

 




Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740